MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting

Trial Profile

MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 May 2013

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Acronyms MOTIV; MOTIV-CABG
  • Most Recent Events

    • 16 Mar 2012 Actual patient number (368) added as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top